Zhong-guo S. Zhou
State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
FOLFOX-HAIC versus first-line systemic chemotherapy in HBsAg-positive patients with unresectable intrahepatic cholangiocarcinoma: A propensity score matched cohort study.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: December 18, 2025
Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma.
Journal: The Journal of clinical investigation
Published: September 23, 2025
Comparison of the prognostic value of different inflammation-based scores in patients with hepatocellular carcinoma after Lenvatinib therapy.
Journal: World journal of gastroenterology
Published: September 03, 2025
Pathological response ≥90% predicts survival in HCC treated with neoadjuvant loco-regional therapies: A retrospective cohort study.
Journal: JHEP reports : innovation in hepatology
Published: April 14, 2025
Integrated genetic and epigenetic analysis reveals DNA repair alterations in multifocal hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: August 06, 2022
Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review.
Journal: Frontiers in public health
Published: April 12, 2022
Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
Journal: International journal of cancer
Published: November 12, 2020
Preventive effect of celecoxib in sorafenib-related hand-foot syndrome in hepatocellular carcinoma patients, a single-center, open-label, randomized, controlled clinical phase III trial.
Journal: American journal of cancer research
Published: March 13, 2020
Association between dietary patterns and prognosis of hepatocellular carcinoma in the Guangdong liver cancer cohort study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 16, 2020
The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
Journal: Oncogene
Published: January 12, 2020
Intention to control low central venous pressure reduced blood loss during laparoscopic hepatectomy: A double-blind randomized clinical trial.
Journal: Surgery
Published: January 09, 2020
Last Updated: 09/26/2026